IntoCell, Inc.
Develops platform technologies for Antibody-Drug Conjugates (ADCs) for oncology.
287840 | KO
Overview
Corporate Details
- ISIN(s):
- KR7287840003
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 대덕구 신일동로 101, 대전광역시
- Website:
- https://intocell.com/
Description
IntoCell, Inc. is a biotechnology company specializing in the research and development of platform technologies for Antibody-Drug Conjugates (ADCs). The company's core focus is on creating novel biopharmaceuticals, primarily for oncology applications. IntoCell develops proprietary technologies, including its OHPAS™ linker and Payload Modification Technology (PMT™), which are designed to improve the stability, efficacy, and safety of ADC therapeutics. The company advances its own drug pipeline and also collaborates with other pharmaceutical companies through technology transfer and partnership agreements to commercialize its ADC platforms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-16 00:00 |
증권발행실적보고서
|
Korean | 136.8 KB | ||
| 2025-05-15 00:00 |
분기보고서 (2025.03)
|
Korean | 665.6 KB | ||
| 2025-05-12 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 546.3 KB | ||
| 2025-05-12 00:00 |
[기재정정]투자설명서
|
Korean | 3.4 MB | ||
| 2025-05-12 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 28.5 KB | ||
| 2025-05-07 00:00 |
투자설명서
|
Korean | 2.8 MB | ||
| 2025-05-02 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 2.9 MB | ||
| 2025-04-10 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.9 MB | ||
| 2025-03-27 00:00 |
사업보고서 (2024.12)
|
Korean | 866.1 KB | ||
| 2025-03-25 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 2.6 MB | ||
| 2025-03-24 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 17.3 KB | ||
| 2025-03-24 00:00 |
증권신고서(지분증권)
|
Korean | 2.5 MB | ||
| 2024-12-26 00:00 |
[기재정정]분기보고서 (2024.09)
|
Korean | 1.2 MB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 618.6 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 594.6 KB |
Automate Your Workflow. Get a real-time feed of all IntoCell, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IntoCell, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IntoCell, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
